A Study to Assess the Efficacy and Safety of Afimkibart (Also Known as RO7790121) for Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis
Clinical trial NCT06589986 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06589986
- Sponsor
- Hoffmann-La Roche
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-09-17
- Primary completion
- 2027-01-30
- Enrollment
- 400
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.